Trastuzumab botidotin

Trastuzumab botidotin is an antibody-drug conjugate (Antibody-Drug Conjugates) targeting HER2, formed by conjugating Trastuzumab (HY-P9907) with Duostatin-5 (HY-145149). Trastuzumab botidotin exerts antitumor effects through microtubule (Microtubule) inhibition and the ADCC mechanism. Trastuzumab botidotin can be used for HER2-positive breast cancer and HER2-positive solid tumors.

For research use only. We do not sell to patients.

  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00